Figure S2 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G<sub>1</sub>–S Transition

Stefan A.J. Buck,Annelies Van Hemelryk, Corrina de Ridder,Debra Stuurman, Sigrun Erkens-Schulze, Sem van ’t Geloof, Wilma J. Teubel,Stijn L.W. Koolen,Elena S. Martens-Uzunova,Martin E. van Royen,Ronald de Wit,Ron H.J. Mathijssen,Wytske M. van Weerden

crossref（2024）

引用 0|浏览2

暂无评分

摘要

Combination of docetaxel and darolutamide in PC346C-Enzalutamide resistant cells. A: Dose-response curve with mean normalized viability (+/- SEM) of three separate experiments with technical sextuplicates. Curves were interpolated by non-linear regression analysis and used to determine absolute IC50 value.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Figure S2 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition

Figure S2 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G<sub>1</sub>–S Transition